Citations (189)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (36)
Birgitte-Elise G. Emken, Lars R. Lundell, Lene Wallin, Helge E. Myrvold, Cecilia Engström, Madeleine Montgomery, Anders R. Malm, Tore Lind & Jan G. Hatlebakk. (2017) Effects of omeprazole or anti-reflux surgery on lower oesophageal sphincter characteristics and oesophageal acid exposure over 10 years. Scandinavian Journal of Gastroenterology 52:1, pages 11-17.
Read now
Read now
Carlo Calabrese, Anna Fabbri & Giulio Di Febo. (2007) Long-term management of GERD in the elderly with pantoprazole. Clinical Interventions in Aging 2:1, pages 85-92.
Read now
Read now
Ingela Wiklund, Rolf Carlsson, Ingela Wiklund, Rolf Carlsson, Jonas Carlsson & Hans Glise. (2006) Psychological factors as a predictor of treatment response in patients with heartburn: A pooled analysis of clinical trials. Scandinavian Journal of Gastroenterology 41:3, pages 288-293.
Read now
Read now
R. Befrits, S. Sjöstedt, R. Tour, C.-E. Leijonmarck, L. Hedenborg & M. Backman. (2004) Long-term effects of eradication of Helicobacter pylori on relapse and histology in gastric ulcer patients: a two-year follow-up study. Scandinavian Journal of Gastroenterology 39:11, pages 1066-1072.
Read now
Read now
M. Bortolotti. (2003) Natural history of gastro‐oesophageal reflux disease: the neglected factor. Scandinavian Journal of Gastroenterology 38:12, pages 1204-1208.
Read now
Read now
Keith G Tolman, Jane Chandramouli & John C Fang. (2000) Proton pump inhibitors in the treatment of gastro-oesophageal reflux disease. Expert Opinion on Pharmacotherapy 1:6, pages 1171-1194.
Read now
Read now
Donald O. Castell & Norton J. Greenberger. (1999) A Practical Approach to Heartburn. Hospital Practice 34:12, pages 89-98.
Read now
Read now
R. Carlsson, J. Dent, E. Bolling-Sternevald, F. Johnsson, O. Junghard, K. Lauritsen, S. Riley, L. Lundell. (1998) The Usefulness of a Structured Questionnaire in the Assessment of Symptomatic Gastroesophageal Reflux Disease. Scandinavian Journal of Gastroenterology 33:10, pages 1023-1029.
Read now
Read now
M. Viljakka, M. Luostarinen & J. Isolauri. (1997) Incidence of Antireflux Surgery in Finland 1988-1993: Influence of Proton-Pump Inhibitors and Laparoscopic Technique. Scandinavian Journal of Gastroenterology 32:5, pages 415-418.
Read now
Read now
T. Lind, T. Havelund, R. Carlsson, O. Anker-Hansen, H. Glise, H. Hernqvist, O. Junghard, K. Lauritsen, L. Lundell, S.A. Pedersen & A. Stubberöd. (1997) Heartburn without Oesophagitis: Efficacy of Omeprazole Therapy and Features Determining Therapeutic Response. Scandinavian Journal of Gastroenterology 32:10, pages 974-979.
Read now
Read now
M. Viljakka, J. Nevalainen & J. Isolauri. (1997) Lifetime Costs of Surgical versus Medical Treatment of Severe Gastro-Oesophageal Reflux Disease in Finland. Scandinavian Journal of Gastroenterology 32:8, pages 766-772.
Read now
Read now
T. L. Venables, R. D. Newland, A. C. Patel, J. Hole, M. B. Copeman & M. L. Turbitt. (1997) Maintenance Treatment for Gastro-Oesophageal Reflux Disease: A Placebo-Controlled Evaluation of 10 Milligrams Omeprazole Once Daily in General Practice. Scandinavian Journal of Gastroenterology 32:7, pages 627-632.
Read now
Read now
A. Blomqvist, H. Lönroth, J. Dalenbäck, M. Ruth, I. Wiklund & L. Lundell. (1996) Quality of Life Assessment after Laparoscopic and Open Fundoplications Results of a Prospective, Clinical Study. Scandinavian Journal of Gastroenterology 31:11, pages 1052-1058.
Read now
Read now
G. Van Den Boom, P. M. M. Y. H. Go, W. Hameeteman, B. Dallemagne & A. J. H. A. Ament. (1996) Cost Effectiveness of Medical versus Surgical Treatment in Patients with Severe or Refractory Gastroesophageal Reflux Disease in The Netherlands. Scandinavian Journal of Gastroenterology 31:1, pages 1-9.
Read now
Read now
L. Sterk Laursen, T. Havelund, S. Bondesen, J. Hansen, G. Sanchez, E. Sebelin, C. Fenger & K. Lauritsen. (1995) Omeprazole in the Long-Term Treatment of Gastro-oesophageal Reflux Disease: A Double-Blind Randomized Dose-Finding Study. Scandinavian Journal of Gastroenterology 30:9, pages 839-846.
Read now
Read now
G. N. J. Tytgat. (1995) The Clinical Use of Cisapride in Gastro-oesophageal Reflux Disease, with Particular Focus on the Long-term Treatment Aspects. Scandinavian Journal of Gastroenterology 30:sup211, pages 39-43.
Read now
Read now
A. L. Hillman. (1994) Economic Analysis of Alternative Treatments for Persistent Gastro-Oesophageal Reflux Disease. Scandinavian Journal of Gastroenterology 29:sup201, pages 98-102.
Read now
Read now
T. Havelund, L. S. Laursen & K. Lauritsen. (1994) Efficacy of Omeprazole in Lower Grades of Gastro-Oesophageal Reflux Disease. Scandinavian Journal of Gastroenterology 29:sup201, pages 69-73.
Read now
Read now
J-P. Galmiche & S. Bruley Des Varannes. (1994) Symptoms and Disease Severity in Gastro-Oesophageal Reflux Disease. Scandinavian Journal of Gastroenterology 29:sup201, pages 62-68.
Read now
Read now
N.-O. Stålhammar. (1993) Assessing the Cost-effectiveness of Medical Treatments in Acid-related Diseases: The Markov Chain Approach Applied to a Comparison between Intermittent and Maintenance Treatment of Reflux Esophagitis. Scandinavian Journal of Gastroenterology 28:sup199, pages 8-13.
Read now
Read now
J. G. Hatlebakk, A. Berstad, L. Carling, L. E. Svedberg, P. Unge, P. Ekström, L. Halvorsen, A. Stallemo, N. Hovdenak, R. Trondstad, E. Kittang & O. J. Lange. (1993) Lansoprazole versus Omeprazole in Short-Term Treatment of Reflux Oesophagitis Results of a Scandinavian Multicentre Trial. Scandinavian Journal of Gastroenterology 28:3, pages 224-228.
Read now
Read now
P. Bytzer, T. Havelund & J. Moller Hansen. (1993) Interobserver Variation in the Endoscopic Diagnosis of Reflux Esophagitis. Scandinavian Journal of Gastroenterology 28:2, pages 119-125.
Read now
Read now
B. I. Hirschowitz. (1992) Acid and Pepsin Secretion in Patients with Esophagitis Refractory to Treatment with H2 Antagonists. Scandinavian Journal of Gastroenterology 27:6, pages 449-452.
Read now
Read now
G. N. J. Tytgat, O. J. Anker Hansen, L. Carling, G. H. De Groot, H. Geldof, H. Glise, P. Efskind, L. Elsborg, A. L. Karvonen, B. Ohlin, O. H. Solhaug & B. Vermeersch &. (1992) Effect of Cisapride on Relapse of Reflux Oesophagitis, Healed with an Antisecretory Drug. Scandinavian Journal of Gastroenterology 27:3, pages 175-183.
Read now
Read now
E. C. Klinkenberg-Knol. (1991) Recent Advances in the Management of Gastro-Oesophageal Reflux Disease. Scandinavian Journal of Gastroenterology 26:sup188, pages 101-107.
Read now
Read now
T. Lind, C. Cederberg, J.-P. Idström, H. Lönroth, L. Olbe & L. Lundell. (1991) 24-Hour Intragastric Acidity and Plasma Gastrin during Long-Term Treatment with Omeprazole or Ranitidine in Patients with Reflux Esophagitis. Scandinavian Journal of Gastroenterology 26:6, pages 620-626.
Read now
Read now
L. Lundell, L. Backman, P. Ekström, L.-K. Enander, S. Falkmer, O. Fausa, L. Grimelius, N. Havu, T. Lind, H. Lönroth, S. Sandmark, B. Sandzén, P. Unge & I. H. Westin. (1991) Prevention of Relapse of Reflux Esophagitis after Endoscopic Healing: The Efficacy and Safety of Omeprazole Compared with Ranitidine. Scandinavian Journal of Gastroenterology 26:3, pages 248-256.
Read now
Read now
L. Elsborg & F. Jørgensen. (1991) Sucralfate versus Cimetidine in Reflux Oesophagitis: A Double-Blind Clinical Study. Scandinavian Journal of Gastroenterology 26:2, pages 146-150.
Read now
Read now
J. B. M. J. Jansen & C. B. H. W. Lamers. (1990) High Doses of Ranitidine in Patients with Reflux Oesophagitis. Scandinavian Journal of Gastroenterology 25:sup178, pages 42-46.
Read now
Read now
G. N. J. Tytgat, C. Y. Nio & R. H. Schotborgh. (1990) Reflux Esophagitis. Scandinavian Journal of Gastroenterology 25:sup175, pages 1-12.
Read now
Read now
P. G. Farup, R. Weberg, A. Berstad, S. Wetterhus, O. Dahlberg, J. Dybdahl, G. Fyllingen, K. S. Kannelønning & O. J. Lange. (1990) Low-Dose Antacids versus 400 mg Cimetidine Twice Daily for Reflux Oesophagitis. Scandinavian Journal of Gastroenterology 25:3, pages 315-320.
Read now
Read now
E. J. S. Boyd & J. R. Wood. (1989) H2-Receptor Antagonists in the Treatment of Reflux Oesophagitis. Scandinavian Journal of Gastroenterology 24:sup171, pages 136-143.
Read now
Read now
H. P. M. Festen. (1989) Profound Gastric Acid Inhibition: Advantages and Potential Hazards. Scandinavian Journal of Gastroenterology 24:sup171, pages 99-105.
Read now
Read now
P. Zeitoun. (1989) Comparison of Omeprazole with Ranitidine in the Treatment of Reflux Oesophagitis. Scandinavian Journal of Gastroenterology 24:sup166, pages 83-87.
Read now
Read now
H. Glise. (1989) Healing, Relapse Rates and Prophylaxis of Reflux Esophagitis. Scandinavian Journal of Gastroenterology 24:sup156, pages 57-64.
Read now
Read now
K. G. Wormsley. (1988) Risks of Therapeutic Achlorhydria. Scandinavian Journal of Gastroenterology 23:sup153, pages 35-51.
Read now
Read now
Articles from other publishers (153)
Fahmi Shibli, Dalbir S. Sandhu & Ronnie Fass. (2022) The Discrepancy Between Subjective and Objective Clinical Endpoints in Gastroesophageal Reflux Disease. Journal of Clinical Gastroenterology 56:5, pages 375-383.
Crossref
Crossref
Yasuki Habu, Ryuhei Hamasaki, Motonobu Maruo, Tatsuya Nakagawa, Yuki Aono & Daisaku Hachimine. (2021) Treatment strategies for reflux esophagitis including a potassium‐competitive acid blocker: A cost‐effectiveness analysis in Japan. Journal of General and Family Medicine 22:5, pages 237-245.
Crossref
Crossref
Yasuki Habu. (2019) Vonoprazan versus Lansoprazole for the Initial Treatment of Reflux Esophagitis: A Cost-effectiveness Analysis in Japan. Internal Medicine 58:17, pages 2427-2433.
Crossref
Crossref
Hirota Miyazaki, Ataru Igarashi, Toshihisa Takeuchi, Lida Teng, Akihito Uda, Hisato Deguchi, Kazuhide Higuchi & Toshiro Tango. (2019)
Vonoprazan
versus
proton‐pump inhibitors for healing gastroesophageal reflux disease: A systematic review
. Journal of Gastroenterology and Hepatology.
Crossref
Crossref
Tonya Adamiak & Karen Francolla Plati. (2018) Pediatric Esophageal Disorders: Diagnosis and Treatment of Reflux and Eosinophilic Esophagitis. Pediatrics In Review 39:8, pages 392-402.
Crossref
Crossref
Tom MunyerSean McConachie, Sheila Wilhelm & Marina Kawaguchi-Suzuki. 2017. PharmacotherapyFirst: A Multimedia Learning Resource. PharmacotherapyFirst: A Multimedia Learning Resource.
Tom Munyer. 2017. PharmacotherapyFirst: A Multimedia Learning Resource. PharmacotherapyFirst: A Multimedia Learning Resource.
Taline A Boghossian, Farah Joy Rashid, Wade Thompson, Vivian Welch, Paul Moayyedi, Carlos Rojas-Fernandez, Kevin Pottie & Barbara Farrell. (2017) Deprescribing versus continuation of chronic proton pump inhibitor use in adults. Cochrane Database of Systematic Reviews 2017:3.
Crossref
Crossref
Il-Seok Park. (2016) Dogma of Extraesophaghgeal Reflux. Journal of The Korean Society of Laryngology, Phoniatrics and Logopedics 27:2, pages 78-83.
Crossref
Crossref
P. W. Weijenborg, F. Cremonini, A. J. P. M. Smout & A. J. Bredenoord. (2012) PPI therapy is equally effective in well‐defined non‐erosive reflux disease and in reflux esophagitis: a meta‐analysis. Neurogastroenterology & Motility 24:8, pages 747.
Crossref
Crossref
Paul Moayyedi, Jose Santana, Mostafiz Khan, Cathy Preston & Clare Donnellan. (2011) Medical treatments in the short term management of reflux oesophagitis. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Paul Kuo & Richard H. Holloway. (2010) A pragmatic symptom-based approach. Best Practice & Research Clinical Gastroenterology 24:6, pages 765-773.
Crossref
Crossref
Richard H Holloway. (2009) Questionnaires in gastroesophageal reflux disease: What do the answers mean?. Journal of Gastroenterology and Hepatology 24:8, pages 1311-1312.
Crossref
Crossref
Joel E. Richter. 2008. Pearson's Thoracic and Esophageal Surgery. Pearson's Thoracic and Esophageal Surgery
192
201
.
C. Daniel Smith & David A. McCluskyIIIIII. 2008. Surgery. Surgery
791
826
.
Paul Moayyedi, Jose Santana, Mostafiz Khan, Cathy Preston & Clare Donnellan. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Ary Nasi, Joaquim Prado P. de Moraes-Filho & Ivan Cecconello. (2006) Doença do refluxo gastroesofágico: revisão ampliada. Arquivos de Gastroenterologia 43:4, pages 334-341.
Crossref
Crossref
Paul Moayyedi & Nicholas J Talley. (2006) Gastro-oesophageal reflux disease. The Lancet 367:9528, pages 2086-2100.
Crossref
Crossref
L. LUNDELL, N. HAVU, P. MIETTINEN, H. E. MYRVOLD, L. WALLIN, R. JULKUNEN, K. LEVANDER, J. G. HATLEBAKK, B. LIEDMAN, M. LAMM, A. MALM & A. WALAN. (2006) Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial. Alimentary Pharmacology and Therapeutics 23:5, pages 639-647.
Crossref
Crossref
Ernst Eypasch, Edmund A.M. Neugebauer, F. Fischer, Hans Troidl, A.L. Blum, D. Collet, A. Cuschieri, B. Dallemagne, H. Feussner, K.-H. Fuchs, H. Glise, C.K. Kum, T. Lerut, L. Lundell, H.E. Myrvold, A. Peracchia, H. Petersen & J.J.B. van Lanschot. 2006. EAES Guidelines for Endoscopic Surgery. EAES Guidelines for Endoscopic Surgery
97
124
.
S. Wood-Dauphinee & D. Korolija. 2006. Gastroesophageal Reflux Disease. Gastroesophageal Reflux Disease
269
285
.
L K Nathanson, S Shimi & A Cuschieri. (1991) Laparoscopic ligamentum teres (round ligament) cardiopexy. British Journal of Surgery 78:8, pages 947-951.
Crossref
Crossref
Yasuki Habu, Kazuo Maeda, Takeo Kusuda, Takuya Yoshino, Seiji Shio, Maki Yamazaki, Takanobu Hayakumo, Kyohei Hayashi, Yoshiyuki Watanabe & Keiichi Kawai. (2005) “Proton-pump inhibitor-first” strategy versus “step-up” strategy for the acute treatment of reflux esophagitis: a cost-effectiveness analysis in Japan. Journal of Gastroenterology 40:11, pages 1029-1035.
Crossref
Crossref
T. Wada, M. Sasaki, H. Kataoka, S. Tanida, K. Itoh, N. Ogasawara, T. Oshima, S. Togawa, E. Kubota, T. Yamada, Y. Mori, F. Fujita, H. Ohara, H. Nakao, S. Sobue, T. Joh & M. Itoh. (2005) Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics 21:s2, pages 2-9.
Crossref
Crossref
D. Armstrong, S. J. O. Veldhuyzen van Zanten, A. N. Barkun, N. Chiba, A. B. R. Thomson, S. Smyth, P. Sinclair, B. Chakraborty & R. J. White. (2005) Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care - the CADET-HR Study. Alimentary Pharmacology and Therapeutics 21:10, pages 1189-1202.
Crossref
Crossref
Kenneth R. DeVault & Donald O. Castell. (2005) Updated Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease. The American Journal of Gastroenterology 100:1, pages 190-200.
Crossref
Crossref
Elaine McColl, Ola Junghard, Ingela Wiklund & Dennis A. Revicki. (2005) Assessing Symptoms in Gastroesophageal Reflux Disease: How Well Do Clinicians' Assessments Agree with Those of Their Patients?. The American Journal of Gastroenterology 100:1, pages 11-18.
Crossref
Crossref
Radu Tutuian & Donald O. Castell. (2003) Management of Gastroesophageal Reflux Disease. The American Journal of the Medical Sciences 326:5, pages 309-318.
Crossref
Crossref
Joshua Cohen. (2003) Switching Omeprazole in Sweden and the United States. American Journal of Therapeutics 10:5, pages 370-376.
Crossref
Crossref
G. Deboever, C. Wagner, Nadine Bourgeois, Vinciane Muls, J. Belaïche, Marie-Agnès Azerad, C. Fassotte, Hilde Dhont & Ilse Van Bogaert. (2003) Le lansoprazole 15 mg OD est supérieur à la ranitidine 300 mg OD dans le soulagement du pyrosis et pour la guérison des patients souffrant d’œsophagite de reflux de grade I (confirmé par endoscopie)Lansoprazole 15 mg OD is superior to ranitidine 300 mg OD in relieving heartburn and healing patients with (endoscopically confirmed) reflux oesophagitis grade I. Acta Endoscopica 33:4, pages 573-585.
Crossref
Crossref
Lauren B. Gerson. (2003) WHAT IS THE BEST CURE FOR CHRONIC GERD? THE ONGOING DEBATE BETWEEN MEDICAL AND SURGICAL THERAPY. Evidence-Based Gastroenterology 4:2, pages 34-36.
Crossref
Crossref
Karna Dev Bardhan. (2003) Intermittent and on-Demand Use of Proton Pump Inhibitors in The Management of Symptomatic Gastroesophageal Reflux Disease. American Journal of Gastroenterology 98, pages S40-S48.
Crossref
Crossref
P. Lindberg, D. Keeling, J. Fryklund, T. Andersson, P. Lundborg & E. Carlsson. (2003) Esomeprazole - enhanced bio-availability, specificity for the proton pump and inhibition of acid secretion. Alimentary Pharmacology & Therapeutics 17:4, pages 481-488.
Crossref
Crossref
L Lundell, J Dalenbäck, E Janatuinen, J Hattlebakk, K Levander, P Miettinen, H E Myrvold, S A Pedersen, K Thor, A Andersson & N O Stålhammar. (1998) Comprehensive 1-year cost analysis of open antireflux surgery in Nordic countries. British Journal of Surgery 85:7, pages 1002-1005.
Crossref
Crossref
L Rydberg, M Ruth & L Lundell. (1999) Mechanism of action of antireflux procedures. British Journal of Surgery 86:3, pages 405-410.
Crossref
Crossref
William Chey, Bidan Huang & Robert L. Jackson. (2003) Lansoprazole and Esomeprazole in Symptomatic GERD. Clinical Drug Investigation 23:2, pages 69-84.
Crossref
Crossref
D. C. Metz & W. J. Bochenek. (2003) Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis. Alimentary Pharmacology & Therapeutics 17:1, pages 155-164.
Crossref
Crossref
Loren Laine & Jennifer Sugg. (2002) Effect of Helicobacter pylori Eradication on Development of Erosive Esophagitis and Gastroesophageal Reflux Disease Symptoms: A Post Hoc Analysis of Eight Double Blind Prospective Studies. American Journal of Gastroenterology 97:12, pages 2992-2997.
Crossref
Crossref
Jose Alves de Freitas. (2002) Effectiveness and Tolerability of Rabeprazole 20mg as Once-Daily Monotherapy in Treatment of Erosive or Ulcerative Gastro-Oesophageal Reflux Disease. Clinical Drug Investigation 22:5, pages 279-289.
Crossref
Crossref
Colin W. Howden, E. David BallardIIII & Weining Robieson. (2002) Evidence for Therapeutic Equivalence of Lansoprazole 30mg and Esomeprazole 40mg in the Treatment of Erosive Oesophagitis. Clinical Drug Investigation 22:2, pages 99-109.
Crossref
Crossref
L. García, G. Losada & J.M. Bordas. (2001) Una paciente de 75 años con tos. FMC - Formación Médica Continuada en Atención Primaria 8:10, pages 698-703.
Crossref
Crossref
Joel E. Richter, Peter J. Kahrilas, Stephen J. Sontag, Thomas O.G. Kovacs, Bidan Huang & Jennifer L. Pencyla. (2001) Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients. The American Journal of Gastroenterology 96:11, pages 3089-3098.
Crossref
Crossref
Jeffrey D. Linder & C. Mel Wilcox. (2001) ACID PEPTIC DISEASE IN THE ELDERLY. Gastroenterology Clinics of North America 30:2, pages 363-376.
Crossref
Crossref
Jan G. Hatlebakk & Arnold Berstad. 2001. Barrett’s Esophagus. Barrett’s Esophagus
121
135
.
C. Daniel Smith. 2001. Surgery. Surgery
455
488
.
Ragnar BefritsSvante SjöstedtBengt Ödman, Heléne Sörngård & Greger Lindberg. (2008)
Curing
Helicobacter pylori
Infection in Patients with Duodenal Ulcer Does Not Provoke Gastroesophageal Reflux Disease
. Helicobacter 5:4, pages 202-205.
Crossref
Crossref
P. J. Kahrilas, E. M. M. Quigley, D. O. Castell & S. J. Spechler. (2001) The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 14:11, pages 1503-1509.
Crossref
Crossref
Ph. Houcke, D. Goldfain, P. Guyot, Th. Helbert, J. Laurent, J. F. Rey, D. Rouhier, J. Cassigneul, B. Marchetti, A. Papazian & M. Laurence. (2000) Prévention des récidives de l’oesophagite par reflux par le lansoprazole: 30 mg un jour sur deux ou 15 mg tous les jours?Prevention of relapse of gastro-oesophageal reflux disease by lansoprazole: 30 mg every other day or 15 mg daily?. Acta Endoscopica 30:3, pages 243-253.
Crossref
Crossref
Gustavo R. Heudebert, Robert M. Centor, Joshua C. Klapow, Robert Marks, Lawrence Johnson & C. Mel Wilcox. (2000) What is heartburn worth?. Journal of General Internal Medicine 15:3, pages 175-182.
Crossref
Crossref
Philip O Katz & Donald O Castell. (2000) Medical therapy of supraesophageal gastroesophageal reflux disease. The American Journal of Medicine 108:4, pages 170-177.
Crossref
Crossref
Lauren B Gerson, Anthony S Robbins, Alan Garber, John Hornberger & George Triadafilopoulos. (2000) A Cost-Effectiveness Analysis of Prescribing Strategies in The Management of Gastroesophageal Reflux Disease. American Journal of Gastroenterology 95:2, pages 395-407.
Crossref
Crossref
M.A. Martín Alonso, M.A. Vallecillol Sande, P. Díezl Redondo & R.E. Madrigal Domínguez. (2000) Aspectos terapéuticos del reflujo gastroesofágico. Medicine - Programa de Formación Médica Continuada Acreditado 8:1, pages 31-37.
Crossref
Crossref
Edmund Neugebauer & Stefan Sauerland. 2000. Recommendations for evidence-based endoscopic surgery. Recommendations for evidence-based endoscopic surgery
47
62
.
Ziad Younes & David A. Johnson. (1999) DIAGNOSTIC EVALUATION IN GASTROESOPHAGEAL REFLUX DISEASE. Gastroenterology Clinics of North America 28:4, pages 809-830.
Crossref
Crossref
Lars Lundell, Pekka Miettinen, Helge E. Myrvold, Sven A. Pedersen, Kjell Thor, Annelie Andersson, Jan Hattlebakk, Niilo Havu, Eero Janatuinen, Kristina Levander, Bengt Liedman & Per Nyström. (1999) Lack of effect of acid suppression therapy on gastric atrophy. Gastroenterology 117:2, pages 319-326.
Crossref
Crossref
D.S. Theodoropoulos, R.F. Lockey, H.W. BoyceJrJr & S.C. Bukantz. (2008) Gastroesophageal reflux and asthma: a review of pathogenesis, diagnosis, and therapy. Allergy 54:7, pages 651-661.
Crossref
Crossref
Lind, Havelund, Lundell, Glise, Lauritsen, Pedersen, Anker‐Hansen, StubberÖD, Eriksson, Carlsson & Junghard. (2001) On demand therapy with omeprazole for the long‐term management of patients with heartburn without oesophagitis—a placebo‐controlled randomized trial. Alimentary Pharmacology & Therapeutics 13:7, pages 907-914.
Crossref
Crossref
Kenneth R DeVault & Donald O Castell. (1999) Updated Guidelines for The Diagnosis and Treatment of Gastroesophageal Reflux Disease. American Journal of Gastroenterology 94:6, pages 1434-1442.
Crossref
Crossref
P. N. Maton, R. Orlando & B. Joelsson. (1999) Efficacy of omeprazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease-a prospective, controlled trial. Alimentary Pharmacology & Therapeutics 13:6, pages 819-826.
Crossref
Crossref
Henk P. M. Festen, Ed Schenk, Gie Tan, Pleun Snel & Frits Nelis. (1999) Omeprazole Versus High-Dose Ranitidine in Mild Gastroesophageal Reflux Disease: Short- and Long-Term Treatment. American Journal of Gastroenterology 94:4, pages 931-936.
Crossref
Crossref
Peter J Kahrilas, Brian M Fennerty & Bo Joelsson. (1999) High- Versus Standard-Dose Ranitidine for Control of Heartburn in Poorly Responsive Acid Reflux Disease: A Prospective, Controlled Trial. American Journal of Gastroenterology 94:1, pages 92-97.
Crossref
Crossref
Lars Lundell & John Dent. 1999. Proton Pump Inhibitors. Proton Pump Inhibitors
223
235
.
Philip O. Katz. (1998) Gastroesophageal Reflux Disease. Journal of the American Geriatrics Society 46:12, pages 1558-1565.
Crossref
Crossref
Isabelle Chabot, Johanne Morin, Kateri Bourbeau & Jocelyne Moisan. (2016) A Comparison of Retrospective and Concurrent Drug Utilization Review of Omeprazole. Journal of Pharmacy Technology 14:5, pages 202-208.
Crossref
Crossref
Pietro Gambitta, Amedeo Indriolo, Paola Colombo, Claudio Grosso, Zenia Pirone, Alfredo Rossi, Marta Bini, Giulio Zanasi & Raffaele Arcidiacono. (1998) Management of patients with gastroesophageal reflux disease: a long-term, follow-up study. Current Therapeutic Research 59:5, pages 275-287.
Crossref
Crossref
J. M. Lee & C. A. O'Morain. (1998) Trends in the management of gastro-oesophageal reflux disease.. Postgraduate Medical Journal 74:869, pages 145-150.
Crossref
Crossref
David L Earnest, Ernst Dorsch, James Jones, Dennis E Jennings & Pamela A Greski-Rose. (1998) A Placebo-Controlled Dose-Ranging Study of Lansoprazole in the Management of Reflux Esophagitis. American Journal of Gastroenterology 93:2, pages 238-243.
Crossref
Crossref
L. LUNDELL. (2010) New information relevant to long-term management of endoscopy-negative reflux disease. Alimentary Pharmacology & Therapeutics 11, pages 93-98.
Crossref
Crossref
R. J. F. Laheij, J. L. Severens, J. B. M. J. Jansen, E. H. van de Lisdonk & A. L. M. Verbeek. (1997) Management in General Practice of Patients With Persistent Dyspepsia. Journal of Clinical Gastroenterology 25:4, pages 563-567.
Crossref
Crossref
M Viljakka. (1997) Complications of Open and Laparoscopic Antireflux Surgery: 32-Year Audit at a Teaching Hospital. Journal of the American College of Surgeons 185:5, pages 446-450.
Crossref
Crossref
John M. Wo & J. Patrick Waring. (1997) MEDICAL THERAPY OF GASTROESOPHAGEAL REFLUX AND MANAGEMENT OF ESOPHAGEAL STRICTURES. Surgical Clinics of North America 77:5, pages 1041-1062.
Crossref
Crossref
William R. Garnett & Susan M. Garabedian‐Ruffalo. (2012) Identification, Diagnosis, and Treatment of Acid‐Related Diseases in the Elderly: Implications for Long‐Term Care. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 17:5, pages 938-958.
Crossref
Crossref
I.C.Eric Wesdorp, Willem Dekker & Henk P.M Festen. (1997) Factors predicting relapse during maintenance treatment with famotidine in patients with healed reflux esophagitis. Clinical Therapeutics 19:5, pages 1048-1057.
Crossref
Crossref
J.-P. Galmiche, P. Barthelemy & B. Hamelin. (1997) Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Alimentary Pharmacology and Therapeutics 11:4, pages 765-773.
Crossref
Crossref
R. Carlsson, J.‐P. Galmiche, J. Dent, L. Lundell & L. Frison. (2003) Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta‐analysis of long‐term omeprazole trials. Alimentary Pharmacology & Therapeutics 11:3, pages 473-482.
Crossref
Crossref
Jouko Isolauri, Markku Luostarinen, Mikko Viljakka, Erika Isolauri, Olavi Keyriläinen & Anna-Liisa Karvonen. (1997) Long-Term Comparison of Antireflux Surgery Versus Conservative Therapy for Reflux Esophagitis. Annals of Surgery 225:3, pages 295-299.
Crossref
Crossref
Katsuya Fujimori, Eiichi Suzuki & Masaaki Arakawa. (1997) Effects of omeprazole and cisapride treatment in Japanese asthmatics with reflux esophagitis. Allergology International 46:3, pages 167-172.
Crossref
Crossref
Susan C. Kalish, Rhonda L. Bohn & Jerry Avorn. (1997) Policy Analysis of the Conversion of Histamine2 Antagonists to Over-the-Counter Use. Medical Care 35:1, pages 32-48.
Crossref
Crossref
Ryan A Harris, Miriam Kuppermann & Joel E Richter. (1997) Prevention of Recurrences of Erosive Reflux Esophagitis: A Cost-Effectiveness Analysis of Maintenance Proton Pump Inhibition. The American Journal of Medicine 102:1, pages 78-88.
Crossref
Crossref
Eric Hassall. (1996) Macroscopic Versus Microscopic Diagnosis of Reflux Esophagitis: Erosions or Eosinophils?. Journal of Pediatric Gastroenterology & Nutrition 22:3, pages 321-325.
Crossref
Crossref
Kathy L. Koppelo & Barbara Kaplan. (1996) Management of Gastroesophageal Reflux Disease_16. Journal of the American Pharmaceutical Association (1996) 36:1, pages 17-26.
Crossref
Crossref
Vasilios A Skoutakis, Ronald H Joe & Dimitri S Hara. (2016) Comparative Role of Omeprazole in The Treatment of Gastroesophageal Reflux Disease. Annals of Pharmacotherapy 29:12, pages 1252-1262.
Crossref
Crossref
Sergio Vigneri, Rosanna Termini, Gioacchino Leandro, Salvatore Badalamenti, Maurizio Pantalena, Vincenzo Savarino, Francesco Di Mario, Giuseppe Battaglia, Giuseppe Sandro Mela, Alberto Pilotto, Mario Plebani & Giovanni Davi. (1995) A Comparison of Five Maintenance Therapies for Reflux Esophagitis. New England Journal of Medicine 333:17, pages 1106-1110.
Crossref
Crossref
W. C. ORR, M. H. MELLOW & M. R. GROSSMAN. (2007)
Patterns of 24‐hour oesophageal acid exposure after acute withdrawal of acid suppression
. Alimentary Pharmacology & Therapeutics 9:5, pages 571-574.
Crossref
Crossref
L. Lundell, M. Ruth, N. Sandberg & M. Bove-Nielsen. (1995) Does massive obesity promote abnormal gastroesophageal reflux?. Digestive Diseases and Sciences 40:8, pages 1632-1635.
Crossref
Crossref
J. MÖSSNER, A. H. HÖLSCHER†R. HERZ & A. SCHNEIDER. (2007) A double‐blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis : a multicentre trial. Alimentary Pharmacology & Therapeutics 9:3, pages 321-326.
Crossref
Crossref
K. D. BARDHAN. (2008) The role of proton pump inhibitors in the treatment of gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 9, pages 15-25.
Crossref
Crossref
D. G. COLIN-JONES. (2008) The role and limitations of H2-receptor antagonist in the treatment of gastro-oesophageal refrux disease. Alimentary Pharmacology & Therapeutics 9, pages 9-14.
Crossref
Crossref
R. H. HUNT. (2008) The relationship between the control of pH and healing and symptom relief in gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 9, pages 3-7.
Crossref
Crossref
K. D. BARDHAN, C. J. HAWKEY, R. G. LONG, A. G. MORGAN, K. G. WORMSLEY, I. K. MOULES & D. BROCKLEBANK. (2007) Lansoprazole versus ranitidine for the treatment of reflux oesophagitis. Alimentary Pharmacology & Therapeutics 9:2, pages 145-151.
Crossref
Crossref
Bengt Hallerbäck, Peter Unge, Lasse Carling, Björn Edwin, Hans Glise, Nilu Havu, Ebbe Lyrenäs & Kjell Lundberg. (1994) Omeprazole or ranitidine in long-term treatment of reflux esophagitis. Gastroenterology 107:5, pages 1305-1311.
Crossref
Crossref
KENNETH R. DE VAULT & DONALD O. CASTELL. (1994) Current Diagnosis and Treatment of Gastroesophageal Reflux Disease. Mayo Clinic Proceedings 69:9, pages 867-876.
Crossref
Crossref
W. A. De BOER & G. N. J. TYTGAT. (2007) Review article: drug therapy for reflux oesophagitis. Alimentary Pharmacology & Therapeutics 8:2, pages 147-157.
Crossref
Crossref
Robert D. Marks, Joel E. Richter, John Rizzo, Robert E. Koehler, Jerry G. Spenney, Thomas P. Mills & Gregory Champion. (1994) Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis. Gastroenterology 106:4, pages 907-915.
Crossref
Crossref
John M. Howard, Richard P. E. Reynolds, John V. Frei, Michele A. Flowers, T. J. McDonald, Kim Tilbe & Donald C. Bondy. (1994) Macroscopic healing of esophagitis does not improve esophageal motility. Digestive Diseases and Sciences 39:3, pages 648-654.
Crossref
Crossref
Martin J. Collen, David A. Johnson & Michael J. Sheridan. (1994) Basal acid output and gastric acid hypersecretion in gastroesophageal reflux disease. Digestive Diseases and Sciences 39:2, pages 410-417.
Crossref
Crossref
J. M. L. M. Horbach, M. H. Cnossen, J. B. M. J. Jansen, C. B. H. W. Lamers, A. H. Zwinderman, J. L. Terpstra & H. G. Gooszen. (1994) A prospective study of effects of belsey MK IV antireflux surgery on endoscopic esophagitis, lower esophageal sphincter pressure, and 24-Hr pH measurements. Digestive Diseases and Sciences 39:2, pages 385-392.
Crossref
Crossref
E Kuster, E Ros, V Toledo-Pimentel, A Pujol, J M Bordas, L Grande & C Pera. (1994) Predictive factors of the long term outcome in gastro-oesophageal reflux disease: six year follow up of 107 patients.. Gut 35:1, pages 8-14.
Crossref
Crossref
G. Pozzato, F. Franzin, M. Moretti, T. Lachin, G. Benedetti, R. Sablich, M. Marin, M. Stebel & L. Campanacci. (1994) Effects of omeprazole on ethanol metabolism: an in vitro and in vivo rat and human study. Pharmacological Research 29:1, pages 47-58.
Crossref
Crossref
A. Cuschieri, L. K. Nathanson & S. M. Shimi. 1994. Operationslehre der Endoskopischen Chirurgie 1. Operationslehre der Endoskopischen Chirurgie 1
300
318
.
S Cucchiara, R Minella, C Iervolino, M T Franco, A Campanozzi, M Franceschi, F D'Armiento & S Auricchio. (1993) Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis.. Archives of Disease in Childhood 69:6, pages 655-659.
Crossref
Crossref
S. GORE, C. J. HEALEY, R. SUTTON, I. A. EYRE‐BROOK, M. W. L. GEAR, N. A. SHEPHERD & S. P. WILKINSON. (2007) Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy. Alimentary Pharmacology & Therapeutics 7:6, pages 623-628.
Crossref
Crossref
H. L. WALDUM, E. BRENNA, P. M. KLEVELAND, A. K. SANDVIK & U. SYVERSEN. (2007) Review article: the use of gastric acid‐inhibitory drugs—physiological and pathophysiological considerations. Alimentary Pharmacology & Therapeutics 7:6, pages 589-596.
Crossref
Crossref
I. C. E. Wesdorp, W. Dekker & H. P. M. Festen. (1993) Efficacy of famotidine 20 mg twice a day versus 40 mg twice a day in the treatment of erosive or ulcerative reflux esophagitis. Digestive Diseases and Sciences 38:12, pages 2287-2293.
Crossref
Crossref
G. BIANCHI PORRO & F. PACE. (2009) Rationale and efficacy of medical therapy for gastroesophageal reflux disease. Journal of Internal Medicine 234:4, pages 387-396.
Crossref
Crossref
D Talbot. (1993) TREATMENT OF ADULT PYLORIC STENOSIS: A PHARMACOLOGICAL ALTERNATIVE?. International Journal of Clinical Practice 47:4, pages 220-221.
Crossref
Crossref
S. J. SONTAG. (2007) Rolling review: gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 7:3, pages 293-312.
Crossref
Crossref
J. W. FRESTON. (2007) Future prospects for proton pump inhibitors. Alimentary Pharmacology & Therapeutics 7, pages 68-75.
Crossref
Crossref
G. BRUNNER, R. ARNOLD, U. HENNIG & W. FUCHS. (2007) An open trial of long-term therapy with lansoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment. Alimentary Pharmacology & Therapeutics 7, pages 51-55.
Crossref
Crossref
C. S. ROBERTSON, D. F. EVANS, S. J. LEDINGHAM & M. ATKINSON. (2007) Cisapride in the treatment of gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 7:2, pages 181-190.
Crossref
Crossref
M.J. Arens & J. Dent. (1993) Acid pump blockers: what are their current therapeutic roles?. Baillière's Clinical Gastroenterology 7:1, pages 95-128.
Crossref
Crossref
M. ROBINSON, D. L. DECKTOR, P. N. MATON, S. SABESIN, W. ROUFAIL, D. KOGUT, W. ROBERTS, A. McCULLOUGH, P. PARDOLL, L. SACO, V. RUSTGI & T. KOVACSHU. (2007) Omeprazole is superior to ranitidine plus metoclopramide in the short‐term treatment of erosive oesophagitis. Alimentary Pharmacology & Therapeutics 7:1, pages 67-73.
Crossref
Crossref
W. LONDONG, J. PHILLIPS, N. J. JOHNSON & J. R. WOOD. (2007) The effect of combined therapy with ranitidine and pirenzepine in the treatment of reflux oesophagitis. Alimentary Pharmacology & Therapeutics 6:5, pages 609-618.
Crossref
Crossref
Risto Roine, Rolando Hern�ndez-Mu�oz, Enrique Baraona, Robert Greenstein & Charles S. Lieber. (1992) Effect of omeprazole on gastric first-pass metabolism of ethanol. Digestive Diseases and Sciences 37:6, pages 891-896.
Crossref
Crossref
David A. Johnson. (1992) Medical therapy for gastroesophageal reflux disease. The American Journal of Medicine 92:5, pages S88-S97.
Crossref
Crossref
David Armstrong, Marcel Nicolet, Phillippe Monnier, Germain Chapuis, Marcel Savary & André L. Blum. (1992) Maintenance therapy: Is there still a place for antireflux surgery?. World Journal of Surgery 16:2, pages 300-307.
Crossref
Crossref
N J Bell & R H Hunt. (1992) Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease.. Gut 33:1, pages 118-124.
Crossref
Crossref
Stephen J. Sontag, Basil I. Hirschowitz, Stephen Holt, Malcolm G. Robinson, Jose Behar, Malcolm M. Berenson, Arthur Mccullough, Andrew F. Ippoliti, Joel E. Richter, George Ahtaridis, Richard W. McCallum, Daniel J. Pambianco, Reno Z. Vlahcevic, David A. Johnson, Martin J. Collen, David T. Lyon, Thomas J. Humphries, Angeline Cagliola & Rayanne S. Berman. (1992) Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: The U.S. multicenter study. Gastroenterology 102:1, pages 109-118.
Crossref
Crossref
A. Cuschieri, L. K. Nathanson & S. M. Shimi. 1992. Operative Manual of Endoscopic Surgery. Operative Manual of Endoscopic Surgery
280
297
.
William R. Garnett & George Earl DukesJr.Jr.. 1992. Applied Therapeutics. Applied Therapeutics
375
396
.
J Toussaint, A Gossuin, M Deruyttere, F Huble & G Devis. (1991) Healing and prevention of relapse of reflux oesophagitis by cisapride.. Gut 32:11, pages 1280-1285.
Crossref
Crossref
Thomas J. Simon & Deborah C. Bradstreet. (1991) Comparative tolerability profile of omeprazole in clinical trials. Digestive Diseases and Sciences 36:10, pages 1384-1389.
Crossref
Crossref
M. J. S. LANGMAN. (2007) Omeprazole. Alimentary Pharmacology & Therapeutics 5:4, pages 357-364.
Crossref
Crossref
Richard H. Holloway & Susan R. Orenstein. (1991) Gastro-oesophageal reflux disease in adults and children. Baillière's Clinical Gastroenterology 5:2, pages 337-370.
Crossref
Crossref
Herbert Koop & Rudolf Arnold. (1991) Long-term maintenance treatment of reflux esophagitis with omeprazole. Digestive Diseases and Sciences 36:5, pages 552-557.
Crossref
Crossref
John A. Oates, Alastair J.J. Wood & Paul N. Maton. (1991) Omeprazole. New England Journal of Medicine 324:14, pages 965-975.
Crossref
Crossref
S. Holt & C. W. Howden. (1991) Omeprazole. Digestive Diseases and Sciences 36:4, pages 385-393.
Crossref
Crossref
James A. Koufman. (1991) The Otolaryngologic Manifestations of Gastroesophageal Reflux Disease (GERD): A Clinical Investigation of 225 Patients Using Ambulatory 24-Hour pH Monitoring and an Experimental Investigation of the Role of Acid and Pepsin in the Development of Laryngeal. The Laryngoscope 101, pages 1-78.
Crossref
Crossref
Doug W Piper, Neville D Yeomans & David J C Shearman. (1991) Omeprazole and acid peptic disease. Medical Journal of Australia 154:6, pages 374-375.
Crossref
Crossref
J. DENT, C. G. BREMNER, M. J. COLLEN, R. C. HAGGITT & S. J. SPECHLER. (2008) Barrett's oesophagus. Journal of Gastroenterology and Hepatology 6:1, pages 1-22.
Crossref
Crossref
Karsten Lauritsen, Bent Nyboe Andersen, Laurits Stærk Laursen, Jeppe Hansen, Troels Havelund, Jan Eriksen, Jens F. Rehfeld, Johan Kjærgaard & Jörgen Rask-madsen. (1991) Omeprazole 20 mg three days a week and 10 mg daily in prevention of duodenal ulcer relapse. Gastroenterology 100:3, pages 663-669.
Crossref
Crossref
Lars Lundell, Hasse Abrahamsson, Magnus Ruth, Nils Sandberg & Lars C. Olbe. (1991) Lower esophageal sphincter characteristics and esophageal acid exposure following partial or 360‡ fundoplication: Results of a prospective, randomized, clinical study. World Journal of Surgery 15:1, pages 115-120.
Crossref
Crossref
P. N. Maton, G. Sachs & B. Wallmark. 1991. Pharmacology of Peptic Ulcer Disease. Pharmacology of Peptic Ulcer Disease
159
187
.
M. J. Collen. 1991. Pharmacology of Peptic Ulcer Disease. Pharmacology of Peptic Ulcer Disease
325
348
.
John A. Oates, Alastair J.J. Wood, Mark Feldman & Michael E. Burton. (1990)
Histamine
2
-Receptor Antagonists
. New England Journal of Medicine 323:25, pages 1749-1755.
Crossref
Crossref
H. KOOP, J. HOTZ, G. POMMER, M. KLEIN & R. ARNOLD. (2007) Prospective evaluation of omeprazole treatment in reflux oesophagitis refractory to H2-receptor antagonists. Alimentary Pharmacology & Therapeutics 4:6, pages 593-599.
Crossref
Crossref
E. C. KLINKENBERG-KNOL & S. G. M. MEUWISSEN. (2007) Combined gastric and oesophageal 24-hour pH monitoring and oesophageal manometry in patients with reflux disease, resistant to treatment with omeprazole.. Alimentary Pharmacology & Therapeutics 4:5, pages 485-495.
Crossref
Crossref
C M Bate, P W Keeling, C O'Morain, S P Wilkinson, D N Foster, R A Mountford, J M Temperley, R F Harvey, D G Thompson & M Davis. (1990) Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations.. Gut 31:9, pages 968-972.
Crossref
Crossref
Stephen j. Sontag. (1990) The Medical Management of Reflux Esophagitis. Gastroenterology Clinics of North America 19:3, pages 683-712.
Crossref
Crossref
G.N.J. Tytgat, J.J. Nicolai & F.C. Reman. (1990) Efficacy of different doses of cimetidine in the treatment of reflux esophagitis. Gastroenterology 99:3, pages 629-634.
Crossref
Crossref
John M. Howard & Nicole G.H. Le Riche. (1990) The management of NSAID gastropathy. Baillière's Clinical Rheumatology 4:2, pages 269-291.
Crossref
Crossref
E M Brett. (1990) "It isn't epilepsy is it, doctor?".. BMJ 300:6740, pages 1604-1606.
Crossref
Crossref
T V Taylor & S Holt. (1990) Antireflux surgery.. BMJ 300:6740, pages 1603-1604.
Crossref
Crossref
Thomas A. Lampkin, Daniele Ouellet, Lawrence J. Hak & George E. Dukes. (2016) Omeprazole: A Novel Antisecretory Agent for the Treatment of Acid-Peptic Disorders. DICP 24:4, pages 393-402.
Crossref
Crossref
M Guslandi, S Passaretti & A Tittobello. (1990) Towards a better assessment of reflux oesophagitis.. Gut 31:4, pages 481-481.
Crossref
Crossref
R. F. P. QUIK, M. J. COOPER, M. GLEESON, E. HENTSCHEL, K. SCHUETZE, R. D. KINGSTON & M. MITCHELL. (2007) A comparison of two doses of nizatidine versus placebo in the treatment of reflux oesophagitis. Alimentary Pharmacology & Therapeutics 4:2, pages 201-211.
Crossref
Crossref
L. LUNDELL, L. BACKMAN, P. EKSTRÖM, L.‐H. ENANDER, O. FAUSA, T. LIND, H. LÖNROTH, S. SANDMARK, B. SANDZÉN, P. UNGE & I. H. WESTIN. (2007)
Omepmazole or high‐dose ranitidine in the treatment of patients with reflux oesophagitis not responding to ‘standard doses’of H
2
‐receptor antagonists
. Alimentary Pharmacology & Therapeutics 4:2, pages 145-155.
Crossref
Crossref
J. Hotz. 1990. Motilitätsstörungen im oberen Gastrointestinaltrakt. Motilitätsstörungen im oberen Gastrointestinaltrakt
41
68
.
Per Lindberg, Arne Brändström, Björn Wallmark, Hillevi Mattsson, Leif Rikner & Kurt‐Jürgen Hoffmann. (2006) Omeprazole: The first proton pump inhibitor. Medicinal Research Reviews 10:1, pages 1-54.
Crossref
Crossref
Aryeh Hurwitz & Charles A. Carter. (2016) The Pharmacology of Antiulcer Drugs. DICP 23:10_suppl, pages S10-S16.
Crossref
Crossref
D G Colin-Jones. (1989) Histamine-2-receptor antagonists in gastro-oesophageal reflux.. Gut 30:10, pages 1305-1308.
Crossref
Crossref
Carrie P. Ogorek & Robert S. Fisher. (1989) Detection and Treatment of Gastroesophageal Reflux Disease. Gastroenterology Clinics of North America 18:2, pages 293-313.
Crossref
Crossref
Anders Walan, Jean-Pierre Bader, Meinhard Classen, Cornelis B.H.W. Lamers, Douglas W. Piper, Kerstin Rutgersson & Sven Eriksson. (1989) Effect of Omeprazole and Ranitidine on Ulcer Healing and Relapse Rates in Patients with Benign Gastric Ulcer. New England Journal of Medicine 320:2, pages 69-75.
Crossref
Crossref